Researcher.Life Logo

Immunity, inflammation and disease : Impact Factor & More

eISSN: 2050-4527pISSN: 2050-4527
JournalOpen Access

Key Metrics

CiteScore
2.6
Impact Factor
< 5
SJR
Q3Immunology
SNIP
0.58
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Immunity, inflammation and disease

Immunity, inflammation and disease Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Article-by-article
Article Processing ChargesEUR 2550 | GBP 2100 | USD 3267
Publication Time8
Editorial Review ProcessPeer review
General Details
LanguageEnglish
FrequencyArticle-by-article
Publication Start Year2013
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 8
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessPeer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Immunity, inflammation and disease ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Immunity, inflammation and disease

The Unprecedented Influenza Epidemic of 2024/2025: Overshadowing the COVID‐19 Winter Wave and Exploring Viral Interference
  • 20 Nov 2025
  • Immunity, Inflammation and Disease
The Imbalanced Patterns and Clinical Significance of Cytokines in Acute Myeloid Leukemia Microenvironment
  • 10 Nov 2025
  • Immunity, Inflammation and Disease
Research Progress of Annexin A1 and Its Derived Peptides in the Diagnosis and Treatment of Circulatory Diseases
  • 10 Nov 2025
  • Immunity, Inflammation and Disease
Chimeric Antigen Receptor T‐Cell Therapy and Autoimmune Diseases in the Nervous System
  • 1 Nov 2025
  • Immunity, Inflammation and Disease
Tacrolimus Trough Concentration‐Escalating Bipartite Therapy (Glucocorticoids Combined With Tacrolimus) for Refractory MDA5 Antibody‐Positive Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Pneumonia
  • 1 Nov 2025
  • Immunity, Inflammation and Disease
Clonorchis sinensis Crude Antigen Suppresses Osteoclast Differentiation via Modulation of the NF‐κB and MAPK Signaling Pathway
  • 1 Nov 2025
  • Immunity, Inflammation and Disease
The Unprecedented Influenza Epidemic of 2024/2025: Overshadowing the COVID‐19 Winter Wave and Exploring Viral Interference
  • 20 Nov 2025
  • Immunity, Inflammation and Disease
The Imbalanced Patterns and Clinical Significance of Cytokines in Acute Myeloid Leukemia Microenvironment
  • 10 Nov 2025
  • Immunity, Inflammation and Disease
Research Progress of Annexin A1 and Its Derived Peptides in the Diagnosis and Treatment of Circulatory Diseases
  • 10 Nov 2025
  • Immunity, Inflammation and Disease
Chimeric Antigen Receptor T‐Cell Therapy and Autoimmune Diseases in the Nervous System
  • 1 Nov 2025
  • Immunity, Inflammation and Disease
Tacrolimus Trough Concentration‐Escalating Bipartite Therapy (Glucocorticoids Combined With Tacrolimus) for Refractory MDA5 Antibody‐Positive Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Pneumonia
  • 1 Nov 2025
  • Immunity, Inflammation and Disease
Clonorchis sinensis Crude Antigen Suppresses Osteoclast Differentiation via Modulation of the NF‐κB and MAPK Signaling Pathway
  • 1 Nov 2025
  • Immunity, Inflammation and Disease

FAQs on Immunity, inflammation and disease